P E Keck

2.5k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

P E Keck is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, P E Keck has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 7 papers in Clinical Psychology and 5 papers in Pharmacology. Recurrent topics in P E Keck's work include Bipolar Disorder and Treatment (17 papers), Schizophrenia research and treatment (11 papers) and Electroconvulsive Therapy Studies (8 papers). P E Keck is often cited by papers focused on Bipolar Disorder and Treatment (17 papers), Schizophrenia research and treatment (11 papers) and Electroconvulsive Therapy Studies (8 papers). P E Keck collaborates with scholars based in United States, Netherlands and Germany. P E Keck's co-authors include S L McElroy, Susan L. McElroy, Scott A. West, Ralph Kupka, Gabriele S. Leverich, Willem A. Nolen, A. John Rush, Trisha Suppes, Robert M. Post and Mark A. Frye and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

P E Keck

22 papers receiving 1.7k citations

Hit Papers

Axis I Psychiatric Comorbidity and Its Relationship to Hi... 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P E Keck United States 15 1.4k 641 233 187 171 24 1.9k
Baruch Spivak Israel 25 749 0.6× 492 0.8× 197 0.8× 256 1.4× 105 0.6× 76 1.8k
Erik Nelson United States 18 713 0.5× 958 1.5× 279 1.2× 94 0.5× 138 0.8× 31 1.9k
Mark D. Fossey United States 15 1.2k 0.9× 649 1.0× 267 1.1× 95 0.5× 271 1.6× 22 1.8k
Rex W. Cowdry United States 22 1.1k 0.8× 1.2k 1.9× 189 0.8× 74 0.4× 243 1.4× 39 2.2k
José Manuel Crespo Spain 26 778 0.6× 382 0.6× 183 0.8× 158 0.8× 268 1.6× 54 1.9k
Nicola Serroni Italy 29 799 0.6× 693 1.1× 188 0.8× 201 1.1× 342 2.0× 64 1.9k
Ute Lewitzka Germany 20 886 0.7× 432 0.7× 201 0.9× 74 0.4× 174 1.0× 78 1.4k
Nilufar Mossaheb Austria 24 919 0.7× 467 0.7× 155 0.7× 114 0.6× 336 2.0× 72 1.8k
Sun Hwang United States 17 669 0.5× 495 0.8× 141 0.6× 62 0.3× 109 0.6× 24 1.7k
Clemente García‐Rizo Spain 29 1.3k 1.0× 355 0.6× 125 0.5× 209 1.1× 175 1.0× 105 2.4k

Countries citing papers authored by P E Keck

Since Specialization
Citations

This map shows the geographic impact of P E Keck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P E Keck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P E Keck more than expected).

Fields of papers citing papers by P E Keck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P E Keck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P E Keck. The network helps show where P E Keck may publish in the future.

Co-authorship network of co-authors of P E Keck

This figure shows the co-authorship network connecting the top 25 collaborators of P E Keck. A scholar is included among the top collaborators of P E Keck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P E Keck. P E Keck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelly, Christopher, Michael J. Ostacher, Bernardo Dell’Osso, et al.. (2025). The influence of depressive and manic symptoms on suicidal ideation in mixed mood states. International Journal of Bipolar Disorders. 13(1). 23–23.
2.
Suppes, Trisha, Gerhard Hellemann, Susan L. McElroy, et al.. (2014). Mixed Depression in the Stanley Foundation Bipolar Treatment Network: Prevalence Rate and Clinical Correlates During Naturalistic Follow Up. Biological Psychiatry. 2 indexed citations
3.
Post, Robert M., Gabriele S. Leverich, Lori L. Altshuler, et al.. (2012). Relationship of Prior Antidepressant Exposure to Long-Term Prospective Outcome in Bipolar I Disorder Outpatients. The Journal of Clinical Psychiatry. 73(7). 924–930. 28 indexed citations
4.
McElroy, Susan L., Anna I. Guerdjikova, Nicole Mori, & P E Keck. (2010). Therapeutic potential of new second generation antipsychotics for major depressive disorder. Expert Opinion on Investigational Drugs. 19(12). 1527–1544. 10 indexed citations
5.
Keck, P E & Susan L. McElroy. (2003). Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic. Expert Opinion on Investigational Drugs. 12(4). 655–662. 72 indexed citations
6.
Keck, P E, S. Corya, Susan D. Briggs, M. Case, & Mauricio Tohen. (2003). P.1.089 Analysis of treatment-emergent mania with olanzapine/fluoxetine combination. European Neuropsychopharmacology. 13. S212–S212. 1 indexed citations
7.
Zhang, Fan, P E Keck, Peter D. Feldman, et al.. (2001). Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. Journal of Affective Disorders. 67(1-3). 133–140. 21 indexed citations
8.
McElroy, S L, Trisha Suppes, P E Keck, et al.. (2001). Axis I Psychiatric Comorbidity and Its Relationship to Historical Illness Variables in 288 Patients With Bipolar Disorder. American Journal of Psychiatry. 158(3). 420–426. 539 indexed citations breakdown →
9.
Geracioti, Thomas D., Dewleen G. Baker, Nosakhare N. Ekhator, et al.. (2001). CSF Norepinephrine Concentrations in Posttraumatic Stress Disorder. American Journal of Psychiatry. 158(8). 1227–1230. 354 indexed citations
10.
Nelson, Erik, et al.. (2001). An open trial of olanzapine in the treatment of patients with psychotic depression.. Annals of Clinical Psychiatry. 13(3). 147–151. 14 indexed citations
11.
Keck, P E. (1999). Schizoaffective disorder: role of atypical antipsychotics. Schizophrenia Research. 35. S5–S12. 14 indexed citations
12.
13.
Strakowski, S M, Kenji W. Sax, Susan L. McElroy, et al.. (1998). Course of Psychiatric and Substance Abuse Syndromes Co-Occurring With Bipolar Disorder After a First Psychiatric Hospitalization. The Journal of Clinical Psychiatry. 59(9). 465–471. 140 indexed citations
14.
Keck, P E, S L McElroy, & Jerry A. Bennett. (1996). Health-economic implications of the onset of action of antimanic agents.. PubMed. 57 Suppl 13. 13–8; discussion 19. 14 indexed citations
15.
McElroy, S L, P E Keck, & Stephen M. Strakowski. (1996). Mania, psychosis, and antipsychotics.. PubMed. 57 Suppl 3. 14–26; discussion 47. 53 indexed citations
16.
Strakowski, S M, et al.. (1995). Racial influence on diagnosis in psychotic mania. Biological Psychiatry. 37(9). 604–604. 6 indexed citations
17.
Keck, P E, Susan L. McElroy, Karen C. Tugrul, Jerry A. Bennett, & Jacqueline Smith. (1993). Antiepileptic Drugs for the Treatment of Panic Disorder. Neuropsychobiology. 27(3). 150–153. 22 indexed citations
18.
McElroy, S L, K A Phillips, P E Keck, James I. Hudson, & Harrison G. Pope. (1993). Body dysmorphic disorder: does it have a psychotic subtype?. PubMed. 54(10). 389–95. 46 indexed citations
19.
McElroy, S L & P E Keck. (1993). Treatment guidelines for valproate in bipolar and schizoaffective disorders.. PubMed. 38(3 Suppl 2). S62–6. 23 indexed citations
20.
McElroy, Susan L., Eric C. Dessain, Harrison G. Pope, et al.. (1991). Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.. PubMed. 52(10). 411–4. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026